Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00113789
Status:
COMPLETED
Last Update Posted:
2009-02-13
First Post:
2005-06-10
Brief Title:
Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian Cancer
Sponsor:
Amgen
Organization:
Amgen